At least four state pharmacy boards have taken steps to limit prescriptions of potential coronavirus treatments touted by U.S. President Donald Trump that are in short supply as demand has surged with the rapid spread of the outbreak.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,